Clinical Trial Update: Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes" [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial assesses a weekly GLP-1 receptor agonist for individuals with Double Diabetes and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist (undisclosed)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Double Diabetes | Phase 3 | Status: RECRUITING